FORSPIRO Trademark

Trademark Overview

On Monday, March 25, 2013, a trademark application was filed for FORSPIRO with the United States Patent and Trademark Office. The USPTO has given the FORSPIRO trademark a serial number of 85884993. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 7, 2016. This trademark is owned by Novartis AG. The FORSPIRO trademark is filed in the Medical Instrument Products category with the following description:

Inhalers for medical purposes; Medical apparatus for diagnosing or treating respiratory conditions; Medical apparatus for introducing pharmaceutical preparations into the human body; Nebulizer for administering medication in the form of a mist inhaled into the lungs, for treatment of respiratory diseases
forspiro

General Information

Serial Number85884993
Word MarkFORSPIRO
Filing DateMonday, March 25, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 7, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 6, 2013

Trademark Statements

Goods and ServicesInhalers for medical purposes; Medical apparatus for diagnosing or treating respiratory conditions; Medical apparatus for introducing pharmaceutical preparations into the human body; Nebulizer for administering medication in the form of a mist inhaled into the lungs, for treatment of respiratory diseases
Pseudo MarkFPR SPIRO

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, April 1, 2013
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, November 7, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 7, 2016ABANDONMENT - NO USE STATEMENT FILED
Friday, April 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 14, 2016EXTENSION 5 GRANTED
Tuesday, March 29, 2016EXTENSION 5 FILED
Tuesday, March 29, 2016TEAS EXTENSION RECEIVED
Wednesday, October 7, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 6, 2015EXTENSION 4 GRANTED
Monday, September 28, 2015EXTENSION 4 FILED
Monday, September 28, 2015TEAS EXTENSION RECEIVED
Thursday, April 9, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 8, 2015EXTENSION 3 GRANTED
Friday, March 27, 2015EXTENSION 3 FILED
Friday, March 27, 2015TEAS EXTENSION RECEIVED
Friday, October 24, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 23, 2014EXTENSION 2 GRANTED
Monday, September 29, 2014EXTENSION 2 FILED
Friday, October 10, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 29, 2014TEAS EXTENSION RECEIVED
Tuesday, April 1, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 28, 2014EXTENSION 1 GRANTED
Friday, March 28, 2014EXTENSION 1 FILED
Friday, March 28, 2014TEAS EXTENSION RECEIVED
Tuesday, October 1, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 6, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 6, 2013PUBLISHED FOR OPPOSITION
Wednesday, July 17, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 27, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 27, 2013ASSIGNED TO EXAMINER
Tuesday, April 2, 2013NOTICE OF PSEUDO MARK E-MAILED
Monday, April 1, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 28, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

forspiro medical respiratory apparatus administering form medication mist lungs diseases treatment